Detection of minor populations of drug-resistant HIV-1 in acute seroconverters.
about
Viral population estimation using pyrosequencingEmergence of primary NNRTI resistance mutations without antiretroviral selective pressure in a HAART-treated childLow-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral usePrevalence and impact of minority variant drug resistance mutations in primary HIV-1 infectionMinor HIV-1 variants with the K103N resistance mutation during intermittent efavirenz-containing antiretroviral therapy and virological failureEmergence of minor drug-resistant HIV-1 variants after triple antiretroviral prophylaxis for prevention of vertical HIV-1 transmissionThe prevalence of transmitted resistance to first-generation non-nucleoside reverse transcriptase inhibitors and its potential economic impact in HIV-infected patientsPatterns of transmitted HIV drug resistance in Europe vary by risk groupPrevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failurePrevalence of WHO transmitted drug resistance mutations by deep sequencing in antiretroviral-naïve subjects in Hunan Province, ChinaHow Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts' Opinion and Its Influence on the Projected Public Health ImpactSimultaneous detection of major drug resistance mutations in the protease and reverse transcriptase genes for HIV-1 subtype C by use of a multiplex allele-specific assayTransmitted drug resistance in nonsubtype B HIV-1 infection.Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure.Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy.Minority variants of drug-resistant HIV.Systematic evaluation of allele-specific real-time PCR for the detection of minor HIV-1 variants with pol and env resistance mutationsDetection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants.Primer ID Informs Next-Generation Sequencing Platforms and Reveals Preexisting Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Coding DomainBoth human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients.Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection.Clinical implications of HIV-1 minority variantsMolecular assays for monitoring HIV infection and antiretroviral therapy.Hidden Empirical Research Ethics: A Review of Three Health Journals from 2005 through 2006.Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials.Detection and quantification of minor human immunodeficiency virus type 1 variants harboring K103N and Y181C resistance mutations in subtype A and D isolates by allele-specific real-time PCR.Management of paediatric HIV-1 resistance.The case for addressing primary resistance mutations to non-nucleoside reverse transcriptase inhibitors to treat children born from mothers living with HIV in sub-Saharan Africa.HIV testing and antiretroviral treatment strategies for prevention of HIV infection: impact on antiretroviral drug resistance.Geographic and temporal trends of transmitted HIV-1 drug resistance among antiretroviral-naïve subjects screening for two clinical trials in North America and Western Europe.No Substantial Evidence for Sexual Transmission of Minority HIV Drug Resistance Mutations in Men Who Have Sex with Men.Short communication: Simultaneous substitutions of V38M and N43T-N44K in the gp41 heptad repeat 1 (HR1) disrupt HIV type 1 gPr160 endoproteolytic cleavage (*).MultiCode-RTx real-time PCR system for detection of subpopulations of K65R human immunodeficiency virus type 1 reverse transcriptase mutant viruses in clinical samples.HIV drug resistance in newly diagnosed adults in a rural prefecture of eastern China.Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection.Low-abundance drug-resistant HIV-1 variants: finding significance in an era of abundant diagnostic and therapeutic options.Detection of drug-resistant HIV minorities in clinical specimens and therapy failure.Unique evolution characteristics of the envelope protein of EIAV(LN₄₀), a virulent strain of equine infectious anemia virus.Characterization of HIV-1 Near Full-Length Proviral Genome Quasispecies from Patients with Undetectable Viral Load Undergoing First-Line HAART Therapy.
P2860
Q28472641-DAAB3413-EED1-43E4-8465-AC6D93406E40Q28474989-EC82819D-0BA5-4737-B6FA-D99E113086C6Q28475651-40380694-81A4-4A00-83DE-B72CBD279637Q28478459-2DB7F0BE-109A-47F9-AEDF-8F0E50657D08Q28478779-7777E529-89A8-4782-A545-887E7A6EC6D1Q28481233-5454F190-228E-46BD-96EC-F99D249F592AQ28535577-90620BAD-08C0-41A6-BB4D-8FAF56B3EFD2Q28537726-7CBC4B38-705C-490B-BDCD-9A52AD6392C7Q28539186-E515C9A1-F62B-49F0-A830-C3805837B40EQ28539368-701BFE52-D9A4-4BD0-912E-8A03DE0485C8Q28552455-A29E73B0-0975-42F7-ACB8-ADC6C964D58DQ28660673-BFB7BBCD-5BD8-4BA9-9E34-2D854F23755FQ33567164-02C66695-6C9D-4117-9BB0-51351E0E6ACCQ33672541-78C545EE-77F6-4309-A93E-00606C9F4647Q33749434-8E45C2F1-6637-490F-A649-26275591E571Q34047780-CCDBA530-DA20-439A-A80E-912209C234FCQ34331628-8CBCF4C2-BF3B-4395-9DE4-DB738679DC88Q35140450-54081F6E-394A-4557-A978-B7900C5302C9Q35692184-D6300208-5D02-43AD-B1DF-6A43F01F835AQ35913936-20F33794-90F2-46BB-B1E0-86F98598807DQ36798007-52646855-03B2-443F-841D-2C9FB6188ECAQ36811249-2919906C-9D43-45C6-8A09-8DFCC4923D7FQ36816024-7899E04A-D853-4C4F-A789-DB53B623B318Q37184605-0665D855-A5F3-44E8-960C-0558B40C2FFFQ37189622-F3048929-9B16-4D3E-AD69-7FFCD7737BE5Q37228748-D86D873C-976D-47B5-BE0D-95A6B0098162Q37247625-7139FA7B-368D-443F-8D90-DD6EE8DF96E4Q37326138-BC035485-AD8C-4C5C-AD50-C72548B75778Q37491651-D896C97B-A07D-46EE-B4EC-C110E50B0322Q37935116-89A696B3-C8F2-42F7-9EF3-4C8EA4BEBE68Q38450409-6859E949-4F4D-4485-AD37-AE3A00F1007AQ38644734-99F1598F-BCC7-4B99-AEC1-E33758720DD5Q39754864-DCE776CF-5BA7-4D22-9BA6-4AF6396B2BC0Q41066820-425A61B7-B5E1-4C70-BB6B-046818BACB2BQ42215138-3F8DC9D0-41C7-4694-9F2D-E69497C4D23CQ42255433-19E4D04B-BDE4-4E45-9846-8E59496BA8B5Q42586120-F00960A5-F07E-41A4-B342-861B2DD7BDE3Q44750837-2908A34D-1179-4041-8854-A2BDDD774D26Q45368605-423803A0-8C8F-42B0-A2B5-39C4E5A6C2D3Q47140686-7281F5F8-D576-4C6B-B67A-0EA4AC100FA0
P2860
Detection of minor populations of drug-resistant HIV-1 in acute seroconverters.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Detection of minor populations of drug-resistant HIV-1 in acute seroconverters.
@en
Detection of minor populations of drug-resistant HIV-1 in acute seroconverters.
@nl
type
label
Detection of minor populations of drug-resistant HIV-1 in acute seroconverters.
@en
Detection of minor populations of drug-resistant HIV-1 in acute seroconverters.
@nl
prefLabel
Detection of minor populations of drug-resistant HIV-1 in acute seroconverters.
@en
Detection of minor populations of drug-resistant HIV-1 in acute seroconverters.
@nl
P2093
P1433
P1476
Detection of minor populations of drug-resistant HIV-1 in acute seroconverters.
@en
P2093
Bernhard Zöllner
Christoph Boesecke
Hans-Jürgen Stellbrink
Hauke Walter
Heiko Jessen
Holger Gellermann
Knud Schewe
Stefan Fenske
P304
P356
10.1097/01.AIDS.0000189878.97480.ED
P407
P577
2005-11-01T00:00:00Z